Swiss Life Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $171M | Buy |
680,811
+3,342
| +0.5% | +$719K | 0.71% | 23 |
|
|
2026
Q1 | $147M | Buy |
677,469
+48,777
| +8% | +$10.8M | 0.72% | 23 |
|
|
2025
Q4 | $144M | Sell |
628,692
-243,460
| -28% | -$55.5M | 0.73% | 18 |
|
|
2025
Q3 | $202M | Sell |
872,152
-2,032
| -0.2% | -$414K | 1.05% | 14 |
|
|
2025
Q2 | $162M | Sell |
874,184
-18,356
| -2% | -$3.41M | 0.96% | 18 |
|
|
2025
Q1 | $187M | Buy |
892,540
+70,708
| +9% | +$13.7M | 1.36% | 14 |
|
|
2024
Q4 | $146M | Buy |
821,832
+404,776
| +97% | +$74.4M | 1.08% | 16 |
|
|
2024
Q3 | $82.3M | Sell |
417,056
-11,711
| -3% | -$2.19M | 0.94% | 17 |
|
|
2024
Q2 | $73.5M | Buy |
428,767
+44,550
| +12% | +$7.38M | 0.87% | 19 |
|
|
2024
Q1 | $70M | Buy |
384,217
+37,699
| +11% | +$6.5M | 0.97% | 18 |
|
|
2023
Q4 | $53.7M | Buy |
346,518
+12,253
| +4% | +$1.79M | 0.65% | 23 |
|
|
2023
Q3 | $49.8M | Buy |
334,265
+41,456
| +14% | +$6.09M | 0.77% | 20 |
|
|
2023
Q2 | $39.5M | Buy |
292,809
+4,991
| +2% | +$732K | 0.58% | 26 |
|
|
2023
Q1 | $45.9M | Buy |
287,818
+53,478
| +23% | +$8.18M | 0.69% | 20 |
|
|
2022
Q4 | $37.9M | Sell |
234,340
-17,235
| -7% | -$2.64M | 0.63% | 26 |
|
|
2022
Q3 | $33.8M | Buy |
251,575
+14,020
| +6% | +$2.01M | 0.58% | 29 |
|
|
2022
Q2 | $36.4M | Sell |
237,555
-78,849
| -25% | -$12M | 0.59% | 29 |
|
|
2022
Q1 | $51.3M | Buy |
316,404
+4,099
| +1% | +$595K | 0.72% | 18 |
|
|
2021
Q4 | $42.3M | Sell |
312,305
-51,861
| -14% | -$6.13M | 0.55% | 30 |
|
|
2021
Q3 | $39.3M | Buy |
364,166
+5,951
| +2% | +$680K | 0.54% | 33 |
|
|
2021
Q2 | $34.3M | Buy |
358,215
+37,624
| +12% | +$4.24M | 0.35% | 44 |
|
|
2021
Q1 | $34.7M | Sell |
320,591
-7,638
| -2% | -$817K | 0.5% | 35 |
|
|
2020
Q4 | $35.2M | Buy |
328,229
+247,577
| +307% | +$23.8M | 0.51% | 35 |
|
|
2020
Q3 | $7.06M | Sell |
80,652
-53,249
| -40% | -$5.01M | 0.1% | 153 |
|
|
2020
Q2 | $13.2M | Buy |
133,901
+26,119
| +24% | +$2.3M | 0.21% | 99 |
|
|
2020
Q1 | $8.21M | Buy |
107,782
+52,111
| +94% | +$4.44M | 0.16% | 124 |
|
|
2019
Q4 | $4.93M | Sell |
55,671
-46,819
| -46% | -$3.89M | 0.09% | 186 |
|
|
2019
Q3 | $7.76M | Sell |
102,490
-529,360
| -84% | -$36.3M | 0.1% | 148 |
|
|
2019
Q2 | $45.9M | Buy |
631,850
+55,245
| +10% | +$4.34M | 0.55% | 46 |
|
|
2019
Q1 | $46.5M | Sell |
576,605
-13,485
| -2% | -$1.1M | 0.59% | 46 |
|
|
2018
Q4 | $54.4M | Sell |
590,090
-148,039
| -20% | -$13M | 1.11% | 20 |
|
|
2018
Q3 | $69.8M | Sell |
738,129
-417,203
| -36% | -$39.6M | 0.94% | 19 |
|
|
2018
Q2 | $107M | Buy |
1,155,332
+324,209
| +39% | +$31.7M | 1.6% | 7 |
|
|
2018
Q1 | $78.7M | Buy |
831,123
+475,920
| +134% | +$52.3M | 1.38% | 12 |
|
|
2017
Q4 | $34.4M | Sell |
355,203
-78,707
| -18% | -$7.42M | 0.77% | 36 |
|
|
2017
Q3 | $38.5M | Buy |
433,910
+54,293
| +14% | +$4.13M | 1.03% | 22 |
|
|
2017
Q2 | $27.5M | Buy |
379,617
+23,609
| +7% | +$1.59M | 0.71% | 32 |
|
|
2017
Q1 | $23.2M | Buy |
356,008
+80,422
| +29% | +$5.06M | 0.63% | 40 |
|
|
2016
Q4 | $17.3M | Buy |
275,586
+61,337
| +29% | +$3.74M | 0.58% | 56 |
|
|
2016
Q3 | $13.5M | Buy |
214,249
+58,125
| +37% | +$3.76M | 0.46% | 57 |
|
|
2016
Q2 | $9.66M | Hold |
156,124
| – | – | 0.4% | 72 |
|
|
2016
Q1 | $8.92M | Sell |
156,124
-25,926
| -14% | -$1.45M | 0.38% | 72 |
|
|
2015
Q4 | $10.8M | Buy |
182,050
+10,926
| +6% | +$629K | 0.48% | 61 |
|
|
2015
Q3 | $9.31M | Buy |
171,124
+38,910
| +29% | +$2.53M | 0.45% | 64 |
|
|
2015
Q2 | $8.88M | Sell |
132,214
-4,921
| -4% | -$321K | 0.31% | 66 |
|
|
2015
Q1 | $8.03M | Buy |
+137,135
| New | +$8.28M | 0.32% | 71 |
|
Other funds holding ABBV
Swiss Life Asset Management's ABBV Position: Q2 2026 in Review
Swiss Life Asset Management increased its AbbVie (ABBV) stake by 0.49% in Q2 2026, buying an estimated $719K and bringing the position to 680,811 shares worth $171M. The position accounts for 0.71% of the portfolio, ranked #23.
Swiss Life Asset Management first reported a position in ABBV in Q1 2015 and has held it in 46 quarters since. The position peaked at $202M in Q3 2025. 3,317 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Swiss Life Asset Management held 680,811 shares of AbbVie worth $171M as of Q2 2026.
- Swiss Life Asset Management bought 3,342 AbbVie shares in Q2 2026, an estimated $719K.
- AbbVie made up 0.71% of Swiss Life Asset Management's portfolio in Q2 2026, its #23 holding.
- Swiss Life Asset Management first reported a position in AbbVie in Q1 2015 and has held it in 46 quarters since.
- Swiss Life Asset Management's AbbVie position peaked at $202M in Q3 2025.
- 3,317 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.